“BMT Across the World: Who Makes What and Who Pays Whom?” is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) and the EBMT (European Society for Blood and Marrow Transplantation), scheduled for December 11, 2025, at 9:00 AM CST.

Focusing on allogeneic Bone Marrow Transplantation (BMT), the session aims to explore the significant variations in the clinical, logistical, administrative, and reimbursement landscapes for BMT therapies across different countries. Key topics include how BMT is regulated, implemented, and paid for globally, alongside a critical appraisal of emerging innovations in areas such as GVHD prophylaxis, conditioning regimens, and relapse prevention.

Register.